Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Supplementing pharmaceutical analysis techniques using radiotracers.

Hans-Christian Holten Lützhøft1, Christian Foged, Stella R Rasmussen

  • 1CMC Development, Novo Nordisk A/S, Novo Nordisk Park, DK-2760 Måløv, Denmark.

Journal of Pharmaceutical Sciences
|April 7, 2004
PubMed
Summary

Radiolabeling helps track drug degradation and mass balance in solid formulations. This study used radiotracers to accelerate degradation studies for levormeloxifene, identifying oxidation to an N-oxide as the primary pathway.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia.

Nature·2026
Same author

Identification of long non-coding RNAs involved in leukemogenesis and venetoclax response in acute myeloid leukemia through functional CRISPR-dCas9 interference screens.

Non-coding RNA research·2026
Same author

An exploratory study of environmental and nutritional determinants of early-stage clonal hematopoiesis in the elderly.

Environment international·2026
Same author

A multi-center study on the consistency of drug sensitivity testing in patients with acute myeloid leukemia.

NPJ precision oncology·2026
Same author

Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy <i>versus</i> liposomal cytarabine and daunorubicin.

Haematologica·2026
Same author

Decoding the actionable potential of ribosome biogenesis in acute myeloid leukemia.

Haematologica·2026

Area of Science:

  • Pharmaceutical Sciences
  • Radiochemistry
  • Analytical Chemistry

Background:

  • Radiolabeled compounds offer sensitive detection for drug degradation studies.
  • Understanding drug degradation pathways and mass balance is crucial for solid dosage forms.

Purpose of the Study:

  • To investigate degradation pathways and mass balance of levormeloxifene using radiolabeling.
  • To demonstrate radiotracers as a supplement and cross-validation tool for conventional analytical methods.
  • To accelerate stability studies using enhanced stress conditions.

Main Methods:

  • Utilized radiolabeled levormeloxifene in solid dosage form.
  • Employed pilot studies with high oxygen pressure and elevated temperatures to mimic degradation.
  • Analyzed degradation products using liquid chromatography with mass spectrometric detection.

Related Experiment Videos

Main Results:

  • Successfully accelerated the degradation study time significantly.
  • Identified oxidation of the pyrrolidine nitrogen atom to an N-oxide as the major degradation pathway.
  • Demonstrated the utility of radiotracers in drug substance analysis.

Conclusions:

  • Radiolabeling is effective for elucidating drug degradation pathways and mass balance.
  • Accelerated stability testing using enhanced conditions can dramatically reduce study duration.
  • Radiotracers provide valuable cross-validation for traditional analytical techniques in pharmaceutical development.